Table 2. Use of hospital resources and outcomes.
| Non-COVID-19 | COVID-19 | p-Value | |
|---|---|---|---|
| n = 185 | n = 212 | ||
| Invasive support | |||
| Vasopressors–n (%) | 84 (45.4) | 108 (50.9) | 0.317 |
| Invasive mechanical ventilation–n (%) | 26 (14.1) | 105 (49.5) | <0.001 |
| Renal replacement therapy–n (%) | 9 (4.9) | 28 (13.2) | 0.007 |
| ECMO–n (%) | 0 (0.0) | 8 (3.8) | 0.021 |
| Transfusion–n (%) | 24 (13.0) | 35 (16.5) | 0.397 |
| Parenteral Nutrition–n (%) | 5 (2.7) | 13 (6.1) | 0.163 |
| Non-invasive positive pressure ventilation–n (%) | 55 (29.7) | 104 (49.1) | <0.001 |
| High flow nasal cannula–n (%) | 12 (6.5) | 99 (46.7) | <0.001 |
| Tracheostomy–n (%) | 2 (1.1) | 23 (10.8) | <0.001 |
| Outcomes | |||
| Duration of MV days–median [IQR] | 4.00 [2.00–11.75] | 9.00 [6.00–16.00] | 0.003 |
| NIV failure–n (%) | 4 (2.2) | 43 (20.3) | <0.001 |
| 28-day all-cause mortality–n (%) | 27 (14.6) | 19 (9.0) | 0.066 |
| 60-day all-cause mortality–n (%) * | 32 (17.3) | 23 (10.8) | 0.087 |
| 28-day mortality in ventilated patients–n (%) * | 9/26 (34.6%) | 17/105 (16.2%) | 0.114 |
| ICU LOS–days median [IQR] | 3.00 [2.00–4.00] | 7.00 [2.00–15.00] | <0.001 |
| Hospital LOS–days median [IQR] | 12.00 [7.00–24.00] | 17.50 [11.00–31.00] | <0.001 |
*Three patients were excluded because they were still in patients with a follow-up shorter than 60 days.